1 / 23

Status presentation on BRCC project- Gujarat

CUTS INTERNATIONAL. Status presentation on BRCC project- Gujarat. 26 th June, 2012. Presentation P oints. About Raman Development Consultants (RDC) Overview of Pharma sector in Gujarat Team RDC- BRCC Project, Gujarat Regulations & Process in Pharma sector

garson
Download Presentation

Status presentation on BRCC project- Gujarat

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CUTS INTERNATIONAL Status presentation on BRCC project- Gujarat 26th June, 2012

  2. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Presentation Points • About Raman Development Consultants (RDC) • Overview of Pharma sector in Gujarat • Team RDC- BRCC Project, Gujarat • Regulations & Process in Pharma sector • Sample framework of the research study • Approach and methodology • Interim findings of the study • Social, Environmental & Economical impact

  3. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 About RDC • 22 year old organization registered under Company’s Act, 1956 • Mission: Enhancing social and entrepreneurial capital of India and other developing countries. • RDC has completed more than 800 projects and worked with all major donor agencies and government agencies in India across more than 25 states and also in 7 South Asian countries. • Head Office at Ahmedabad, National Office at Delhi and representative offices in 9 states of India • Focused sectors: Public health, Infrastructure development and public-private partnership, Urban development, Governance & institutional development, Sustainable livelihood, Disaster mitigation. • Services: Policy and strategy development, Behavioral/biological/ social Research, Monitoring & Evaluation, programme design and management, training and capacity building, system design,, MIS, communication/constituency building and development

  4. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Overview of Pharma sector in Gujarat • India’s 2nd domestic Pharmaceutical unit estd. in 1907 • 42% of total Indian Pharmaceutical turnover with valued 4.3 billion US$ (21500 crore INR) • 35 to 46 % share in total Pharma production in India • 22 % of total export of the country • 60000 Employment in the sector • 6 Pharma sanctioned SEZs in the state • 37 Pharma Academic Institutes having 2375 students intake

  5. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Pharma Licenses/Units in Gujarat Source : FDCA - Gujarat

  6. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Team RDC- BRCC Project- Gujarat

  7. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Regulations- Policy, Act, Norm, Authority

  8. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Process of Pharmaceutical sector Continue in next slide

  9. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012

  10. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Approach and Methodology

  11. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Sample size for Pharma sector Source : Department of Pharmaceutical, GoI- 2010

  12. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Sample size for Private hospital

  13. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Status of field work Status as on 18th June, 2012

  14. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Common observations

  15. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Interim findings • Good Manufacturing Process (GMP): Majority of firms are aware about the GMP but general consensus is low rate of compliance in the different segments. • Safe environmental initiative: It is common belief that only bulk drug production units are responsible for environmental pollution. Setups for effluent treatment is not sufficient in the plant or not in working condition. • Regulations: low proactivity for self-regulation, weak system of penalties leading to unethical practice. • Firms are in favor of strict implementation of regulations with generation of transparency in the system.

  16. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Interim findings (cont.) • Cuts and commission: well accepted trade and practices • Accepted by Pharma firm as a marketing policy & • Doctors want solicitation • MRs are the instrument for cut practices • Discussion about cut practices: no formal sector is willing to discuss about cuts and commission but talking is place in informal settings.

  17. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Interim findings (cont.) • Bio-medical waste rule, 1998: Practice under BMW management is not followed in true spirit. • Inadequate training of hospital staff & improper handling • Irregular monitoring from GPCB • No interaction between GPCB and private hospital • No regulation or formal body that monitor the practice of hygiene/ universal precautions maintenance by hospitals • Expressed need for facilitation meetings & training: early dialogue from GPCB is welcomed with aim to improve access to health and safe practices.

  18. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Interim findings (cont.) • System of BMW service providers is not mature: irregular service, high charge • Lack of healthy competition • Monopolistic nature • There is a need for separate study in service providers • Medical code of Ethics,2002: no mechanism in place to ascertain whether in-house or empanelled doctors comply this regulation. • There is continuous inherent distress between doctors and administration & other support staff • Social capital is fragmented • Rational use of drugs: there is sectorial gap between behavior of doctors and rational use of drugs

  19. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Social impact of violation of business responsibility • Social responsibilities are forgotten in Pharma firms as the budget which would be for CSR is being spent for Marketing • Business values are changing, cuts & commission is well accepted trade practice • Self regulation is becoming second responsibility for the sector • Doctor-patient relationship has lost its spirit, patient has become a costumer for doctor.

  20. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Environmental impact of violation of business responsibility • Ignoring environmental importance in the name of ‘Pharma is a non polluting industry’ • Non availability or inadequate waste treatment and disposal facility, discharge of polluted and hazardous Pharma waste in river or land by small and scattered units.

  21. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Economic impact of violation of business responsibility • Violation of Business Responsibility is responsible for inflation • Patients are paying high cost for medicines - Cost effective health is now dream for poor • The prevailing marketing practices in the sector has lost the competition benefits to consumers • Schemes for C & FA, Gifts for stockiest, Discount for distributors, commissions for doctors and benefits to chemists, but not any/minimal concession for consumers

  22. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Open space

  23. RDC/ CUTS/ BRCC-Gujarat : 26-6-2012 Thank you

More Related